Stanford Medicine’s Health Compass podcast brings the latest medical research to life through compelling stories that connect with your everyday health experiences.
A lymphoma driver called BCL6 suppresses the expression of cell death genes. A new molecule designed at Stanford Medicine blocks its activity and activates downstream genes to trigger cell death.
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.
In a paradigm shift, a Stanford Medicine-led study reveals a new role for a well-known protein, tau, linked to Alzheimer’s disease and other neurodegenerative disorders.
The FDA finally gave the green light to bemotrizinol. Stanford Medicine experts explain why this is considered a massive leap forward for skin health in the U.S.
Gynecologists can offer tailored strategies to manage menopause symptoms in breast cancer survivors who can’t use hormone replacement therapy.
Millions of Americans have turned to cheaper, compounded versions. Stanford clinicians explain why they have safety concerns, and what to do if you are taking one.
Researchers are venturing into a new area of collaboration that relies on agentic AI, co-scientists that can act independently and help humans ideate, hypothesize and speed up scientific exploration.
